July earnings matter, but long-term growth matters more.
Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for ...
For Q2, according to Seeking Alpha, analysts are expecting normalized EPS of $1.28, GAAP EPS of $0.97, and $12.52bn of ...
How Abbott Laboratories Stock Has Been Performing Abbott Laboratories has attracted fresh attention from investors after a ...
The U.S. Justice Department closed a criminal probe into Abbott Laboratories over ​its handling of a baby formula plant ...
June 28 (Reuters) - The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby ...
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in a ...
View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Barchart on MSN
Abbott Laboratories' Q2 2026 earnings: What to expect
With a market cap of $162.4 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, ...
Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months.
Over the past few years, the exciting field of artificial intelligence (AI) has captured much of Wall Street's attention and headlines. And sure enough, some of the leaders in AI have produced ...
Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results